Unwarranted optimism about vaccine efficacy
Interim results from phase III trials of the vaccine developed by the University of Oxford and AstraZeneca were announced through press releases on 23 November. Much has been made of an apparent…
Read Original Article: Unwarranted optimism about vaccine efficacy »
